GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the introduction ...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced it was included on ...
The Inogen One G5 Portable Oxygen Concentrator has emerged as a breakthrough solution for individuals requiring supplemental oxygen therapy, combining industry-leading portability with robust ...
Inogen, Inc. INGN is well poised for growth in the coming quarters, courtesy of its high prospects in the portable oxygen concentrator (POC) space. Solid performance in the third quarter of 2022 and a ...
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced preliminary, unaudited revenue results for the ...
Inogen, Inc. INGN incurred an adjusted loss per share of 2 cents for second-quarter 2025, which was narrower than the adjusted loss per share of 7 cents in the year-ago period and the Zacks Consensus ...
Welcome to Inogen's Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, August 7, 2025. I would now like to turn the call over ...
Inogen, Inc. INGN is well-poised for growth in the coming quarters due to high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid third-quarter 2025 performance and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results